Federal Trade Commission accuses three drug middlemen of inflating insulin prices

Get the Full StoryThe Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

Share:

More in Health...

Bans on transgender care for minors may complicate eating disorder treatment

Over 80 sickened after eating raw oysters at Los Angeles restaurant showcase event

FDA approves weight loss drug Zepbound for sleep apnea

Moderate drinking linked to lower risk of death, but there's a major catch

Mystery illness in Congo could be severe malaria, health officials say